P&K Skin Research Center Co., Ltd. (KOSDAQ: 347740)

P&K Skin Research Center Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	6,763	4,813	7,130
Depreciation & Amortization	1,836	1,735	1,468
Loss (Gain) From Sale of Assets	0.31	0	0.97
Loss (Gain) From Sale of Investments	-1,269	-140.01	185.18
Stock-Based Compensation	32.4	65.71	65.98
Provision & Write-off of Bad Debts	41.65	80.73	48.15
Other Operating Activities	665.99	-1,263	-439.34
Change in Accounts Receivable	-494.82	146.84	-753.86
Change in Other Net Operating Assets	1,433	110.94	-198.24
Operating Cash Flow	9,008	5,549	7,507
Operating Cash Flow Growth	57.38%	-26.08%	-
Capital Expenditures	-672.77	-1,526	-1,230
Sale (Purchase) of Intangibles	-	-33.34	-126.01
Investment in Securities	1,333	6,468	-2,457
Other Investing Activities	-10	-786.62	-406.26
Investing Cash Flow	-2,550	972.22	-4,320
Long-Term Debt Repaid	-	-372.54	-318.02
Net Debt Issued (Repaid)	-393.31	-372.54	-318.02
Issuance of Common Stock	-	-	1,495
Repurchase of Common Stock	-2,996	-610.61	-
Dividends Paid	-714.68	-872.08	-892.93
Other Financing Activities	-	149	-0
Financing Cash Flow	-4,104	-1,706	283.73
Foreign Exchange Rate Adjustments	-0.01	0.01	0.03
Net Cash Flow	2,354	4,815	3,471
Free Cash Flow	8,335	4,023	6,277
Free Cash Flow Growth	92.26%	-35.91%	-
Free Cash Flow Margin	47.17%	27.10%	34.95%
Free Cash Flow Per Share	284.49	134.13	210.50
Cash Interest Paid	35.22	30.48	23.93
Cash Income Tax Paid	693.34	1,329	1,178
Levered Free Cash Flow	471.86	-2,996	-
Unlevered Free Cash Flow	489.14	-2,976	-
Change in Net Working Capital	2,417	4,013	-

Source: S&P Capital IQ. Standard template. Financial Sources.